Used in research and development for targeting heparin-binding EGF-like growth factor (HB-EGF), this antibody serves as a critical tool in studying cellular signaling pathways involved in cancer progression, wound healing, and tissue regeneration. It is applied in immunoassays and immunohistochemistry to detect HB-EGF expression in tumor tissues, aiding in the identification of potential therapeutic targets. Due to its specificity, it supports the development of targeted therapies, particularly in oncology drug discovery. It is also utilized in neutralization studies to inhibit HB-EGF activity in cell-based models, helping elucidate the role of HB-EGF in disease mechanisms such as fibrosis and inflammation.